GHK-Cu / KPV Blend — Reconstitution & Research Protocol
I got a lot of questions on the last post asking how you'd reconstitute the GHK-Cu / KPV blend and what a research protocol looks like. So let me do the math for you. This is for research purposes only — not for human consumption. The typical GHK-Cu research dose ranges from 1 to 3mg per day. For most researchers, 2mg is going to be the sweet spot. Since this is a blend, your KPV dose is automatically calculated based on the ratio. Here's how it breaks down for both versions: 50mg GHK-Cu / 10mg KPV Blend (Valor, Ion + Modern Research) The ratio here is 5:1 — five parts GHK-Cu to one part KPV. At a 2mg GHK-Cu research dose, you're getting 0.4mg of KPV per dose. Total doses per vial: 50mg ÷ 2mg = 25 doses. Reconstituted with 3mL of bacteriostatic water (3mL = 300 units on an insulin syringe): 300 units ÷ 25 doses = 12 units per dose. 50mg GHK-Cu / 20mg KPV Blend (AMP, EZ) The ratio here is 5:2 — five parts GHK-Cu to two parts KPV. That's double the KPV compared to the 50/10 blend. At a 2mg GHK-Cu research dose, you're getting 0.8mg of KPV per dose. Total doses per vial: 50mg ÷ 2mg = 25 doses. Reconstituted with 3mL of bacteriostatic water (3mL = 300 units on an insulin syringe): 300 units ÷ 25 doses = 12 units per dose. Both blends give you 25 doses per vial and 12 units per administration — the only difference is how much KPV you're getting per dose. The 50mg/20mg blend gives you double the KPV (0.8mg vs 0.4mg), meaning more anti-inflammatory support per research dose. You can compare pricing on both versions side by side on PeptidePrice: GHK-Cu / KPV Blend 💪